# FERRIC CARBOXYMALTOSE
> **ANDA212572** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2026-06-25
## Drug
- **FDA Application Number:** ANDA212572
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FERRIC CARBOXYMALTOSE
- **Generic name:** FERRIC CARBOXYMALTOSE
- **Active ingredients:** FERRIC CARBOXYMALTOSE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2026-06-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212572)
---
*MORVS · CC0 1.0*